James A. Yergey

3.4k total citations · 1 hit paper
65 papers, 2.5k citations indexed

About

James A. Yergey is a scholar working on Spectroscopy, Molecular Biology and Pharmacology. According to data from OpenAlex, James A. Yergey has authored 65 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Spectroscopy, 18 papers in Molecular Biology and 16 papers in Pharmacology. Recurrent topics in James A. Yergey's work include Mass Spectrometry Techniques and Applications (17 papers), Eicosanoids and Hypertension Pharmacology (13 papers) and Inflammatory mediators and NSAID effects (13 papers). James A. Yergey is often cited by papers focused on Mass Spectrometry Techniques and Applications (17 papers), Eicosanoids and Hypertension Pharmacology (13 papers) and Inflammatory mediators and NSAID effects (13 papers). James A. Yergey collaborates with scholars based in United States, Canada and Czechia. James A. Yergey's co-authors include Deborah A. Nicoll‐Griffith, David N. Heller, Robert J. Cotter, Melvyn P. Heyes, Catherine Fenselau, Sanford P. Markey, Nathalie Chauret, Richard W. Price, Andres Μ. Salazar and John J. Sidtis and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Biochemistry.

In The Last Decade

James A. Yergey

65 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status

1991 479 citations Melvyn P. Heyes, Bruce J. Brew et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James A. Yergey United States	27	728	610	338	337	281	65	2.5k
James L. Meek United States	37	2.5k 3.5×	678 1.1×	252 0.7×	367 1.1×	342 1.2×	69	5.0k
William A. Garland United States	29	1.4k 1.9×	528 0.9×	579 1.7×	207 0.6×	44 0.2×	101	2.9k
M. Strolin Benedetti Italy	37	1.1k 1.6×	311 0.5×	663 2.0×	733 2.2×	21 0.1×	192	4.6k
Leesa J. Deterding United States	44	2.3k 3.1×	1.2k 1.9×	55 0.2×	114 0.3×	156 0.6×	111	4.5k
Michael B. Bolger United States	31	1.3k 1.8×	362 0.6×	437 1.3×	267 0.8×	20 0.1×	77	3.9k
Sandhya Kortagere United States	26	1.4k 2.0×	91 0.1×	309 0.9×	162 0.5×	78 0.3×	76	2.5k
Y. Nancy Wong United States	19	657 0.9×	96 0.2×	344 1.0×	239 0.7×	185 0.7×	38	2.0k
Keiko Yamamoto Japan	36	1.5k 2.1×	181 0.3×	432 1.3×	258 0.8×	84 0.3×	173	4.2k
Jean‐Paul Tillement France	33	1.4k 1.9×	337 0.6×	252 0.7×	331 1.0×	22 0.1×	95	3.1k
Ute F. Röhrig Switzerland	28	1.5k 2.0×	153 0.3×	64 0.2×	153 0.5×	75 0.3×	41	3.2k

Countries citing papers authored by James A. Yergey

Since Specialization

Citations

This map shows the geographic impact of James A. Yergey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Yergey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Yergey more than expected).

Fields of papers citing papers by James A. Yergey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Yergey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Yergey. The network helps show where James A. Yergey may publish in the future.

Co-authorship network of co-authors of James A. Yergey

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Yergey. A scholar is included among the top collaborators of James A. Yergey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Yergey. James A. Yergey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shou, Magang, Yuh J. Lin, Ping Lü, et al.. (2005). Enzyme Kinetics of Cytochrome P450-Mediated Reactions. Current Drug Metabolism. 2(1). 17–36. 59 indexed citations

Leblanc, Yves, Patrick Roy, Zhaoyin Wang, et al.. (2002). Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile. Bioorganic & Medicinal Chemistry Letters. 12(22). 3317–3320. 13 indexed citations

Chauret, Nathalie, Daniel Guay, Chun Li, et al.. (2002). Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: prevention of reactive intermediate formation and covalent binding. Bioorganic & Medicinal Chemistry Letters. 12(16). 2149–2152. 54 indexed citations

Chauret, Nathalie, James A. Yergey, Christine Brideau, et al.. (2001). In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663). Bioorganic & Medicinal Chemistry Letters. 11(8). 1059–1062. 36 indexed citations

Li, Chun, Andrew McClory, Elizabeth Wong, & James A. Yergey. (1999). Mass spectrometric analysis of arachidonyl-containing phospholipids in human U937 cells. Journal of Mass Spectrometry. 34(5). 521–536. 5 indexed citations

Jakobsson, Per‐Johan, Kylie A. Scoggan, James A. Yergey, Joseph A. Mancini, & Anthony W. Ford‐Hutchinson. (1997). Characterization of microsomal GST-II by Western blot and identification of a novel LTC4 isomer. PubMed. 17(1). 15–19. 5 indexed citations

Chun, Li, Nathalie Chauret, Yves Ducharme, et al.. (1995). Integrated Application of Capillary HPLC/Continuous-Flow Liquid Secondary Ion Mass Spectrometry to Discovery Stage Metabolism Studies. Analytical Chemistry. 67(17). 2931–2936. 9 indexed citations

Nicoll‐Griffith, Deborah A., et al.. (1995). Verlukast (MK-0679) conjugation with glutathione by rat liver and kidney cytosols and excretion in the bile.. Drug Metabolism and Disposition. 23(10). 1085–1093. 13 indexed citations

Percival, M. David, Marc Ouellet, C. Vincent, et al.. (1994). Purification and Characterization of Recombinant Human Cyclooxygenase-2. Archives of Biochemistry and Biophysics. 315(1). 111–118. 67 indexed citations

10.

Yergey, James A., et al.. (1994). Respiratory Tract Eicosanoid Measurement Using Microdialysis Sampling and GC/MS Detection. Pulmonary Pharmacology. 7(1). 35–41. 8 indexed citations

11.

Karanian, John W., et al.. (1994). Lipoxygenase stimulating effects of hydroxylated docosahexaenoates produced by human platelets. Prostaglandins Leukotrienes and Essential Fatty Acids. 50(5). 271–278. 4 indexed citations

12.

Gravel, Jocelyn, Jean‐Pierre Falgueyret, James A. Yergey, Laird A. Trimble, & Denis Riendeau. (1993). Identification of 5-Keto-(7E,9E,11Z,14Z)-Eicosatetraenoic Acid as a Novel Nonenzymatic Rearrangement Product of Leukotriene A4. Archives of Biochemistry and Biophysics. 306(2). 469–475. 10 indexed citations

13.

Grossman, Scott, Diane R. Umbenhauer, D Patrick, et al.. (1993). CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.. Drug Metabolism and Disposition. 21(6). 1029–1036. 16 indexed citations

14.

Nicoll‐Griffith, Deborah A., et al.. (1992). In vitro and in vivo biotransformations of the potent leukotriene D4 antagonist verlukast in the rat.. Drug Metabolism and Disposition. 20(3). 383–389. 7 indexed citations

15.

Heyes, Melvyn P., Bruce J. Brew, Alex Martin, et al.. (1991). Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status. Annals of Neurology. 29(2). 202–209. 479 indexed citations breakdown →

16.

Heyes, Melvyn P., Maneth Gravell, Michael D. April, et al.. (1991). Quinolinic Acid Concentrations are Increased in Cerebrospinal Fluid of Rhesus Macaques (Macaca Mulatta) Naturally Infected with Simian Retrovirus Type. Advances in experimental medicine and biology. 294. 555–558. 2 indexed citations

17.

Boni, Riccardo L., et al.. (1991). Stable Isotope-Labeled Tryptophan as a Precursor for Studying the Disposition of Quinolinic Acid in Rabbits. Advances in experimental medicine and biology. 294. 481–484. 2 indexed citations

18.

Heyes, Melvyn P., Allen R. Wyler, Orrin Devinsky, et al.. (1990). Quinolinic Acid Concentrations in Brain and Cerebrospinal Fluid of Patients with Intractable Complex Partial Seizures. Epilepsia. 31(2). 172–177. 52 indexed citations

19.

Yergey, James A., et al.. (1989). Prostaglandins in cerebrospinal fluid of healthy human volunteers, abstinent alcoholics and rhesus monkeys. Prostaglandins. 37(4). 505–517. 9 indexed citations

20.

Karanian, John W., et al.. (1988). Discovery of Novel Brain Lipoxygenase Products Formed from Docosahexaenoic Acid (22:6w3). Advances in Alcohol & Substance Abuse. 7(3-4). 235–240. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact